Odonate Therapeutics Stock Performance
| ODTC Stock | USD 50,000 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Odonate Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Odonate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Odonate Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 181.2 M | |
| Total Cashflows From Investing Activities | -432 K |
Odonate |
Odonate Therapeutics Relative Risk vs. Return Landscape
If you would invest 5,000,000 in Odonate Therapeutics on November 11, 2025 and sell it today you would earn a total of 0.00 from holding Odonate Therapeutics or generate 0.0% return on investment over 90 days. Odonate Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Odonate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Odonate Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Odonate Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Odonate Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Odonate Therapeutics generated a negative expected return over the last 90 days | |
| Net Loss for the year was (126.35 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Odonate Therapeutics currently holds about 95.03 M in cash with (113.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47. |
Odonate Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Odonate Pink Sheet often depends not only on the future outlook of the current and potential Odonate Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Odonate Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 157.3 M |
Odonate Therapeutics Fundamentals Growth
Odonate Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Odonate Therapeutics, and Odonate Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Odonate Pink Sheet performance.
| Return On Equity | -0.86 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | (26.67 M) | |||
| Shares Outstanding | 38.49 M | |||
| Price To Book | 0.89 X | |||
| EBITDA | (125.91 M) | |||
| Cash And Equivalents | 95.03 M | |||
| Cash Per Share | 2.47 X | |||
| Total Debt | 4.85 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | 1.85 X | |||
| Cash Flow From Operations | (113.13 M) | |||
| Earnings Per Share | (2.71) X | |||
| Total Asset | 167.89 M | |||
About Odonate Therapeutics Performance
By analyzing Odonate Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Odonate Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Odonate Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Odonate Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. The company was founded in 2013 and is based in New York, New York. Odonate Therapeutics operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 137 people.Things to note about Odonate Therapeutics performance evaluation
Checking the ongoing alerts about Odonate Therapeutics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Odonate Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Odonate Therapeutics generated a negative expected return over the last 90 days | |
| Net Loss for the year was (126.35 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Odonate Therapeutics currently holds about 95.03 M in cash with (113.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47. |
- Analyzing Odonate Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Odonate Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Odonate Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Odonate Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Odonate Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Odonate Therapeutics' pink sheet. These opinions can provide insight into Odonate Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Odonate Pink Sheet analysis
When running Odonate Therapeutics' price analysis, check to measure Odonate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Odonate Therapeutics is operating at the current time. Most of Odonate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Odonate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Odonate Therapeutics' price. Additionally, you may evaluate how the addition of Odonate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |